Clinical trial
Incidence of Febrile Neutropenia
Prospective observational study of febrile neutropenia (FN) and pegfilgrastim primary prophylaxis in breast cancer and non-Hodgkin's lymphoma patients receiving high (>20%) FN-risk chemotherapy
| Category | Value |
|---|---|
| Study start date | 2014-06-10 |